Psychosocial stress is a major risk factor for the precipitation and exacerbation of mental illness in susceptible individuals. Understanding the neuroadaptations induced by chronic stress could afford new opportunities for therapeutic intervention for stress-related psychiatric disorders. The candidate has shown that levels of the endocannabinoid 2-arachidonoylglycerol (2-AG) exhibit a progressive increase in response to repeated stress exposure in limbic brain regions including the amygdala, and that this increase contributes stress-response habituation.
In aim 1 of this proposal the candidate will determine the temporal dynamics of the 2-AG response to stress and the molecular mechanisms subserving these effects. The candidate will test the hypothesis that the stress hormone corticosterone is required for the adaptations in endogenous cannabinoid signaling to occur in response to repeated stress exposure. Although stress increases 2-AG in the amygdala, it is not known if this increase is associated with enhanced endocannabinoid-mediated synaptic signaling.
In aim 2 the candidate will test the hypothesis that this stress-induced increase in 2-AG in the amygdala is associated with enhanced capacity of amygdala neurons to participate in endocannabinoid-mediated synaptic signaling. Finally, in aim 3, the candidate will test the hypothesis that stress-induced increases in 2-AG levels contribute to the behavioral dysregulation induced by chronic stress. Elucidating the stress-induced adaptations in endocannabinoids signaling could provide novel molecular targets for drug development for the treatment of affective disorders.

Public Health Relevance

Psychosocial stress is major risk factor for development and exacerbation of many forms of metal illness including mood disorders, anxiety disorder, schizophrenia, and substance dependence. Understanding the brain's adaptive response to stress could uncover novel therapeutic approaches to treat these disorders. Determining the adaptations in the endogenous cannabinoid system in response to stress could provide a novel array of endocannabinoid-based molecular targets for drug discovery for the treatment and prevention of a broad spectrum of mental illnesses affected by psychosocial stress.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Neuroendocrinology, Neuroimmunology, and Behavior Study Section (NNB)
Program Officer
Rosemond, Erica K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Schools of Medicine
United States
Zip Code
Shonesy, Brian C; Bluett, Rebecca J; Ramikie, Teniel S et al. (2014) Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Rep 9:1644-53
Hermanson, Daniel J; Gamble-George, Joyonna C; Marnett, Lawrence J et al. (2014) Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends Pharmacol Sci 35:358-67
Ramikie, Teniel S; Nyilas, Rita; Bluett, Rebecca J et al. (2014) Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81:1111-25
Tchantchou, Flaubert; Tucker, Laura B; Fu, Amanda H et al. (2014) The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology 85:427-39
Bluett, R J; Gamble-George, J C; Hermanson, D J et al. (2014) Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Transl Psychiatry 4:e408
Shonesy, Brian C; Wang, Xiaohan; Rose, Kristie L et al. (2013) CaMKII regulates diacylglycerol lipase-? and striatal endocannabinoid signaling. Nat Neurosci 16:456-63
Hermanson, Daniel J; Hartley, Nolan D; Gamble-George, Joyonna et al. (2013) Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat Neurosci 16:1291-8
Gamble-George, Joyonna C; Conger, Jordan R; Hartley, Nolan D et al. (2013) Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Psychopharmacology (Berl) 228:401-9
Ramikie, T S; Patel, S (2012) Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. Neuroscience 204:38-52
Sumislawski, Joshua J; Ramikie, Teniel S; Patel, Sachin (2011) Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 36:2750-61

Showing the most recent 10 out of 11 publications